Home
Conditions
Lupus Erythematosus, Systemic

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies

Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Recruiting

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

NCT06710717

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: University Kebangsaan Malaysia Medical Center Bandar Tun Razak, Kuala Lumpur, Malaysia

View Trial Details

Recruiting

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT06980597

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Beijing Boren Hospital Beijing, China

Beijing GoBroad Hospital Beijing, China

View Trial Details

Recruiting

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

NCT06920433

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

NCT06010472

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Changhai Hospital Shanghai, China

View Trial Details

Recruiting

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

NCT06934447

Conditions: Autoimmune Diseases, BCMA, CAR T Cell Therapy, +5 more
Locations: hildren's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

NCT06503224

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations: Hunan Siweikang Therapeutic Co.Ltd Changsha, Hunan, China

View Trial Details

Recruiting

Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.

NCT06657703

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Peking Union Medical College Hospital Beijing, China

Peking Union Medical College Hospital Beijing, China

The Clinical Pharmacology Research Center of PUMCH Beijing, China

View Trial Details

Recruiting

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

NCT06685042

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +20 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Lazio, Italy

View Trial Details

Recruiting

Chinese Rheumatism Biobank(CRB)

NCT06887517

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Lupus Erythematosus, Systemic

Lupus Erythematosus, Systemic trial results

Related conditions